GlobeNewswire Inc.··NaQuantum BioPharma Adjusts Debenture Terms Amid Share Price Decline
Quantum BioPharma revises debenture offering terms following share price decline, lowering conversion price to $3.00 and increasing warrant allocation.
QNTMwarrantsbiopharmaceutical